Sumeray Mark

Aegerion Pharmaceuticals, Inc.

Chief Medical Officer

Avg. Two Year Performance

No Purchase Track Record

77% Avg. Sale Return 33% Compound

Holdings: 0 shares

Last Three Months: 27-Aug-24 -- 26-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

27-Nov-22 -- 26-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions